Logo
Conferences

Conferences

Catalog

Abstracts

Calendar

Official conference page for 2026 Pittsburgh Skin Cancer Conference.

About 2026 Pittsburgh Skin Cancer Conference

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

54+
Email if you have questions

Faculty and committee

Our Speakers

Faculty

YN

Yana Najjar, MD

Session Chair

Binaytara

PH

Paul Harms, MD, PhD

Session Chair

Binaytara

AM

Ankit Mangla, MD

Session Chair

Binaytara

KC

Kevin J Contrera, MD, MPH

Session Chair

Binaytara

KS

Kathryn Shahwan, MD

Session Chair

Binaytara

JK

John M Kirkwood, MD

Session Chair

Binaytara

DD

Diwakar Davar, MD

Session Chair

Binaytara

MP

Melissa Pugliano-Mauro, MD

Session Chair

Binaytara

KH

Kelly Lynn Harms, MD, PhD

Faculty

Binaytara

KK

Kimberly Ken, MD

Faculty

Binaytara

SS

Shaum Sridharan, MD

Faculty

Binaytara

AG

Ami Greene, MD

Faculty

Binaytara

HG

Hannah Glass, PA-C

Faculty

Binaytara

YS

Yusra Shao, MD

Faculty

Binaytara

DC

David Carr, MD, MPH

Faculty

Binaytara

RP

Ravi Patel, MD, PhD

Faculty

Binaytara

SL

Sancy Leachman, MD, PhD

Faculty

Binaytara

TH

Tarek Haykal, MD

Faculty

Binaytara

YM

Yvonne Mowery, MD, PhD

Faculty

Binaytara

BS

Bhawana Srivastava, MBA

Staff

Binaytara

NB

Nafiso Bakar, Other

Staff

Binaytara

VS

Vivian Scheidt, MA

Staff

Binaytara

EH

Elaina Harris, Other

Staff

Binaytara

Binay Shah

Binay Shah, MD, MHA

Staff

Binaytara

TS

Tara Shah, BSN

Staff

Binaytara

Conference program and agenda

Our Agenda

Saturday, April 11th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

08:00 AM - 09:00 AMRegistration, Breakfast, & Exhibits
09:00 AM - 09:05 AMWelcome
09:05 AM - 09:30 AMBinaytara's Efforts in Improving Cancer Care Disparities
09:30 AM - 10:30 AMSession 1 : Localized and locoregional melanoma

Session Chair: John M Kirkwood, MD; Diwakar Davar, MD

09:30 AM - 10:00 AM

Case-based discussion #1: Role of surgical (SLN) and molecular (GEP) testing in the management of intermediate thickness melanoma – Sancy Leachman, MD, PhD

10:00 AM - 10:30 AM

Case Based discussion #2 : Adjuvant and neoadjuvant therapy in the management of high-risk resectable melanoma – John M Kirkwood, MD

10:30 AM - 10:45 AMBreak & Exhibits
10:45 AM - 11:45 AMSession 2: Management of 1L and 2L cutaneous melanoma

Session Chair: Yana Najjar, MD

10:45 AM - 11:15 AM

Case-based discussion #1: Overview of 1st line options for metastatic cutaneous melanoma. – Tarek Haykal, MD

11:15 AM - 11:45 AM

Case-based discussion #2: 2nd line options including RP1, TIL and clinical trials – Yana Najjar, MD

11:45 AM - 12:45 PMLunch & Exhibits - Product Theater sponsored by Regeneron (non-CME accredited): Adjuvant Treatment with LIBTAYO for Patients with Cutaneous Squamous Cell Carcinoma (CSCC) at High Risk of Recurrence After Surgery and Radiation - John Strasswimmer, MD, PhD
12:45 PM - 01:45 PM Session 3: Biology and Management of MCC

Session Chair: Paul Harms, MD, PhD; Ankit Mangla, MD

12:45 PM - 01:05 PM

Case-based discussion #1: Molecular biology of MCC – Paul Harms, MD, PhD

01:05 PM - 01:25 PM

Case-based discussion #2: Adjuvant and neoadjuvant therapy for MCC (STAMP) – Kelly Lynn Harms, MD, PhD

01:25 PM - 01:45 PM

Case-based discussion #3: Management of advanced MCC – Ankit Mangla, MD

01:45 PM - 02:45 PMSession 4: Adjuvant and neoadjuvant therapy for cSCC and MCC

Session Chair: Kevin J Contrera, MD, MPH

01:45 PM - 02:05 PM

Case-based discussion #1: Neoadjuvant therapy for cSCC – Kevin J Contrera, MD, MPH

02:05 PM - 02:25 PM

Case-based discussion #2: Adjuvant therapy for cSCC (C-POST and KEYNOTE-630) – Shaum Sridharan, MD

02:25 PM - 02:45 PM

Case-based discussion #3: Management of advanced cSCC – Yusra Shao, MD

02:45 PM - 03:00 PMBreak & Exhibits
03:00 PM - 04:20 PMSession 5: Management of advanced NMSC in immunosuppressed patients.

Session Chair: Kathryn Shahwan, MD

03:00 PM - 03:20 PM

Case-based discussion #1: Role of multidisciplinary team in the management of SOTR skin cancers – Kimberly Ken, MD

03:20 PM - 03:40 PM

Case-based discussion #2: Investigational immunotherapy for SOTR NMSC (CONTRAC-1, others) – Ami Greene, MD

03:40 PM - 04:00 PM

Case-based discussion #3: Novel treatments for the management of SOTR cSCC – Kathryn Shahwan, MD

04:00 PM - 04:20 PM

Case- Based Discussion #4 : Cutaneous SCC risk prognostication (riSCC, COMPASS, GEP) – David Carr, MD, MPH

04:20 PM - 05:20 PM Session 6: Survivorship and Radiation Therapy in Non - Melanoma Skin Cancer

Session Chair: Melissa Pugliano-Mauro, MD

04:20 PM - 04:40 PM

Case Based #1: Role of RT in the management of NMSC – Yvonne Mowery, MD, PhD

04:40 PM - 05:00 PM

Case Based #2: RLT and theranostics in melanoma and NMSC – Ravi Patel, MD, PhD

05:00 PM - 05:20 PM

Case Based # 3 : Coordination Of Care in high risk NMSC – Hannah Glass, PA-C

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship